Chris Murphy actually said...

"This increased cost is born by our healthcare system as a whole, but more specifically by patients as more and more insurance companies place higher cost sharing burdens on biologics."

"I hope that we can talk about that today."

"It is a sound strategy, but how is it working?"

"We have to deal with the root causes, but we also have to deal with the humanitarian crisis and help save lives."